featured
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis
Clin. Gastroenterol. Hepatol. 2019 Oct 10;[EPub Ahead of Print], CL Bowlus, PJ Pockros, AE Kremer, A Parés, LM Forman, JPH Drenth, SD Ryder, L Terracciano, Y Jin, A Liberman, R Pencek, U Iloeje, L MacConell, P BedossaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.